VANCOUVER and MINNEAPOLIS - (NewMediaWire) - December 01, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced that its management team will be participating in the Sidoti December Virtual Microcap Conference to be held December 8-9, 2021. Fred Colen, President and...
Read MoreFirst therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS - (NewMediaWire) - November 30, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ (Reducer) system has been granted Prise en Charge Transitoire (PECT) reimbursement in...
Read MoreVANCOUVER and MINNEAPOLIS - (New Media Wire) - November 24, 2021 - Neovasc Inc.("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that in accordance with Nasdaq Listing Rule 5810(c)(3)(A),...
Read MoreVANCOUVER and MINNEAPOLIS - (New Media Wire) - November 24, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ,TSX: NVCN) today announced that the United Kingdoms Interventional Procedures Programme at the National Institute for Health and Care Excellence (NICE) has issued guidance supporting the implantation...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - November 09, 2021 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today reported financial results for the third quarter ended September 30, 2021. Third Quarter Highlights Strong progress against all three value creation strategies. Generated record revenue of approximately...
Read MoreVANCOUVER - (NewMediaWire) - November 01, 2021 - Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the quarter ended September 30, 2021 on Tuesday, November 9, 2021. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, Chief Financial Officer, will host...
Read MorePublication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS - (NewMediaWire) - October 21, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ,TSX: NVCN) today announced that the Neovasc Reducer(TM) (Reducer) is featured in an article published in the...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - September 28, 2021 - Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, Coronary sinus narrowing for the treatment of refractory angina: a multi-centre prospective open-label clinical study (the REDUCER-I study)...
Read More